Investment Trusts

Target Healthcare REIT plc

THRL:LSE

Target Healthcare REIT plc

  • Price (GBX)77.40
  • Today's Change0.90 / 1.18%
  • Shares traded1.35m
  • 1 Year change1.84%
  • Beta0.5418
Data delayed at least 20 minutes, as of Apr 19 2024 18:08 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceTarget Healthcare REIT plc (Ordinary Share)+8.15%
NAVTarget Healthcare REIT plc (Ordinary Share)+9.63%
Morningstar's BenchmarkFTSE EPRA Nareit UK TR GBP--

Announcements

More ▼

Key statistics

On Friday, Target Healthcare REIT plc (THRL:LSE) closed at 77.40, 16.74% above the 52 week low of 66.30 set on Aug 21, 2023.
52-week range
Today
66.30Aug 21 202388.90Jan 04 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding620.24m
Market cap474.48m GBP
Total assets920.53m GBP
Total expense ratio1.50%
High77.40
Low75.50
Previous close76.50
Average volume1.28m
YTD Change-10.31%
Beta0.5418
Diluted NAV (est)111.83
Diluted NAV (last pub)111.50
Premium/Discount-30.79%
Net Gearing+29.30%
Annual div (ADY)5.66 GBX
Annual div yield (ADY)7.39%
Div ex-dateFeb 08 2024
Div pay-dateFeb 23 2024
Data delayed at least 20 minutes, as of Apr 19 2024 18:08 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.